Watermark
  Back to Search Results

BGB-11417-105

Recruiting

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

Ask to Join

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-11417-105

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT04973605

EudraCT or EUCT Number Info icon SVG graphic used for tooltips or additional information.

2021-003614-39

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20231932

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents

Locations

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents